We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email :PharmaSources@imsinoexpo.com
Whatsapp :+86-13621645194
Factory Location: Building 30, Shentian New Office Territory, No. 1525 Minqiang Road, Xinqiao Town, Songjiang District, Shanghai, P.R. China
Main Sales Markets: Asia
Sample Provided: no
Payment Terms: L/C
Chinese hamster ovary (CHO) cells have become the gold standard for biopharmaceutical production and are currently the most widely used mammalian host, especially for the expression of human therapeutic proteins. It has been reported that approximately >70% of recombinant therapeutic proteins are produced in CHO cell systems. CHO cells are capable of more accurate protein glycosylation, assembly and folding like human cells. Therefore, for some proteins whose activity is closely related to post-translational modification, CHO cells become the best production host.The earliest media used for animal-derived cell culture was composed of nutrients such as serum (human or fetal bovine), plasma or tissue extracts, but due to the complex and uncertain components, it caused high variability between batches, and it was easy to increase the risk of contamination. Media without supplementation of serum is a more preferred solution. Serum-free cell culture media are balanced solutions with a chemically defined nutrient composition which is precisely known and defined, ensuring lot-to-lot consistency and eliminating the need to screen new serum lots. For biopharmaceutical manufacturers, who are committed to eliminating all animal-derived components from their manufacturing processes, it is now possible to completely switch to serum-free media solutions when it comes to cell culture media.